Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey MD Tanriover, HL Doğanay, M Akova, HR Güner, A Azap, S Akhan, ... The Lancet 398 (10296), 213-222, 2021 | 953 | 2021 |
Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients U Sili, A Kaya, A Mert, HSV Encephalitis Study Group Journal of Clinical Virology 60 (2), 112-118, 2014 | 215 | 2014 |
Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19 B Kayaaslan, F Eser, AK Kalem, G Kaya, B Kaplan, D Kacar, I Hasanoglu, ... Journal of medical virology 93 (12), 6566-6574, 2021 | 129 | 2021 |
Investigation of SARS-CoV-2 in semen of patients in the acute stage of COVID-19 infection B Kayaaslan, G Korukluoglu, I Hasanoglu, AK Kalem, F Eser, E Akinci, ... Urologia internationalis 104 (9-10), 678-683, 2020 | 121 | 2020 |
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients N Okumuş, N Demirtürk, RA Çetinkaya, R Güner, İY Avcı, S Orhan, ... BMC infectious diseases 21, 1-11, 2021 | 120 | 2021 |
Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg I Hasanoglu, G Korukluoglu, D Asilturk, Y Cosgun, AK Kalem, AB Altas, ... Infection 49, 117-126, 2021 | 118 | 2021 |
The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study F Arslan, E Meynet, M Sunbul, OR Sipahi, B Kurtaran, S Kaya, AC Inkaya, ... European Journal of Clinical Microbiology & Infectious Diseases 34, 1213-1221, 2015 | 107 | 2015 |
Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients B Kayaaslan, F Eser, A Kaya Kalem, Z Bilgic, D Asilturk, I Hasanoglu, ... Mycoses 64 (9), 1083-1091, 2021 | 101 | 2021 |
Crushing the curve, the role of national and international institutions and policy makersin COVID-19 pandemic ZK Tufan, B Kayaaslan Turkish journal of medical sciences 50 (9), 495-508, 2020 | 98 | 2020 |
Adverse effects of oral antiviral therapy in chronic hepatitis B B Kayaaslan, R Guner World journal of hepatology 9 (5), 227, 2017 | 87 | 2017 |
Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever H Bodur, E Akıncı, P Öngürü, Y Uyar, B Baştürk, MG Gözel, BÜ Kayaaslan International Journal of Infectious Diseases 14 (8), e704-e707, 2010 | 82 | 2010 |
COVID-19 and Sepsis ZK Tufan, B Kayaaslan, M Mer Turkish journal of medical sciences 51 (7), 3301-3311, 2021 | 81 | 2021 |
Listerial rhombencephalitis in an immunocompetent young adult BÜ Kayaaslan, E Akıncı, Ş Bilen, MG Gözel, D Erdem, MA Çevik, H Bodur International Journal of Infectious Diseases 13 (2), e65-e67, 2009 | 53 | 2009 |
COVID-19 experience of the major pandemic response center in the capital: results ofthe pandemic's first month in Turkey HR GÜNER, İ Hasanoğlu, B Kayaaslan, A Aypak, AK Kalem, F Eser, ... Turkish journal of medical sciences 50 (8), 1801-1809, 2020 | 52 | 2020 |
Temporal trends in the epidemiology of HIV in Turkey FS Erdinc, B Dokuzoguz, S Unal, S Komur, AC Inkaya, D İnan, ... Current HIV research 18 (4), 258-266, 2020 | 36 | 2020 |
Crimean-Congo hemorrhagic fever: Prognostic factors and the association of leukocyte counts with mortality A Bastug, B Kayaaslan, S Kazancioglu, H Aslaner, A But, E Akinci, ... Japanese journal of infectious diseases 69 (1), 51-55, 2016 | 36* | 2016 |
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study N Buetti, A Tabah, A Loiodice, S Ruckly, AT Aslan, G Montrucchio, ... Critical Care 26 (1), 319, 2022 | 33 | 2022 |
A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol AK Kalem, B Kayaaslan, S Neselioglu, F Eser, I Hasanoglu, A Aypak, ... Free Radical Biology and Medicine 166, 11-17, 2021 | 32 | 2021 |
Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study C Gudiol, X Durà-Miralles, J Aguilar-Company, P Hernández-Jiménez, ... Journal of Infection 83 (3), 306-313, 2021 | 31 | 2021 |
A long-term survey of brucellosis: Is there any marker to predict the complicated cases? B Kayaaslan, A Bastug, E Aydin, E Akinci, A But, H Aslaner, MA Yetkin, ... Infectious Diseases 48 (3), 215-221, 2016 | 26 | 2016 |